During the recent meeting of the World Association of Sleep Medicine (WASM), EARLS proudly presented the results of the study of 11,731 RLS patients from nine European countries as well as the USA and Canada. The WASM organizing committee had accepted threeEARLS presentations: 1. Diagnosis of RLS, 2. Sick leave and disability due to RLS, and 3. dosages used of RLS medicines. The posters attracted a lot of attention. Many lively discussions took place and new ideas were brought forward. The delegates were much impressed by the vast number of questionnaires analysed and the accuracy with which these had been submitted by the RLS patients. The EARLS study was considered special because the population studied were all members of patient organizations.
Thus, EARLS have once again asked for urgent attention for the problems RLS patients are facing in getting a proper diagnosis, in having to stay home from work, and of topics such as augmentation when too high doses of the dopamine agonists are given - which the study has shown occurs all too often.